Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Study of FK463 for the Treatment of Invasive Aspergillosis

This study has been completed.
Information provided by (Responsible Party):
Astellas Pharma Inc Identifier:
First received: May 8, 2002
Last updated: June 12, 2015
Last verified: June 2015